<VariationArchive VariationID="2677683" VariationName="NM_001127649.3(PEX26):c.27_58dup (p.Arg20fs)" VariationType="Duplication" Accession="VCV002677683" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-05" DateCreated="2023-12-30" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2834829" VariationID="2677683">
      <GeneList>
        <Gene Symbol="LOC130066940" FullName="ATAC-STARR-seq lymphoblastoid silent region 13448" GeneID="130066940" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>22q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18078354" stop="18078403" display_start="18078354" display_stop="18078403" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PEX26" FullName="peroxisomal biogenesis factor 26" GeneID="55670" HGNC_ID="HGNC:22965" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>22q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18077990" stop="18105396" display_start="18077990" display_stop="18105396" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="18560685" stop="18573796" display_start="18560685" display_stop="18573796" Strand="+" />
          </Location>
          <OMIM>608666</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001127649.3(PEX26):c.27_58dup (p.Arg20fs)</Name>
      <CanonicalSPDI>NC_000022.11:18078398:CTGCAGCCCCCCTCAGGGGGCTCGGGGGACCCCTGC:CTGCAGCCCCCCTCAGGGGGCTCGGGGGACCCCTGCAGCCCCCCTCAGGGGGCTCGGGGGACCCCTGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18078398" stop="18078399" display_start="18078398" display_stop="18078399" variantLength="32" positionVCF="18078398" referenceAlleleVCF="T" alternateAlleleVCF="TCTGCAGCCCCCCTCAGGGGGCTCGGGGGACCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="18561164" stop="18561165" display_start="18561164" display_stop="18561165" variantLength="32" positionVCF="18561164" referenceAlleleVCF="T" alternateAlleleVCF="TCTGCAGCCCCCCTCAGGGGGCTCGGGGGACCC" />
      </Location>
      <ProteinChange>R20fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.18561169_18561200dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.18561169_18561200dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.18078403_18078434dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.18078403_18078434dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008339.1" sequenceAccession="NG_008339" sequenceVersion="1" change="g.5484_5515dup">
            <Expression>NG_008339.1:g.5484_5515dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008339.2" sequenceAccession="NG_008339" sequenceVersion="2" change="g.5415_5446dup">
            <Expression>NG_008339.2:g.5415_5446dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_201355.1" sequenceAccession="NG_201355" sequenceVersion="1" change="g.150_181dup">
            <Expression>NG_201355.1:g.150_181dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127649.3" sequenceAccession="NM_001127649" sequenceVersion="3" change="c.27_58dup" MANESelect="true">
            <Expression>NM_001127649.3:c.27_58dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121121.1" sequenceAccession="NP_001121121" sequenceVersion="1" change="p.Arg20fs">
            <Expression>NP_001121121.1:p.Arg20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199319.2" sequenceAccession="NM_001199319" sequenceVersion="2" change="c.27_58dup">
            <Expression>NM_001199319.2:c.27_58dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001186248.1" sequenceAccession="NP_001186248" sequenceVersion="1" change="p.Arg20fs">
            <Expression>NP_001186248.1:p.Arg20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017929.6" sequenceAccession="NM_017929" sequenceVersion="6" change="c.27_58dup">
            <Expression>NM_017929.6:c.27_58dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060399.1" sequenceAccession="NP_060399" sequenceVersion="1" change="p.Arg20fs">
            <Expression>NP_060399.1:p.Arg20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001127649.3(PEX26):c.27_58dup (p.Arg20fs) AND Peroxisome biogenesis disorder 7A (Zellweger)" Accession="RCV003476817" Version="1">
        <ClassifiedConditionList TraitSetID="8956">
          <ClassifiedCondition DB="MedGen" ID="C3888385">Peroxisome biogenesis disorder 7A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-17" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127649.3(PEX26):c.27_58dup (p.Arg20fs) AND multiple conditions" Accession="RCV003779068" Version="1">
        <ClassifiedConditionList TraitSetID="10245">
          <ClassifiedCondition DB="MedGen" ID="C3888385">Peroxisome biogenesis disorder 7A (Zellweger)</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3553951">Peroxisome biogenesis disorder 7B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-15" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-12-30" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12851857</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8956" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17436" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 7A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013938" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD7A</ElementValue>
                <XRef ID="GTR000522755" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 8 (CG8, equivalent to CGA) have mutations in the PEX26 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15866" />
                <XRef ID="15866" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3888385" DB="MedGen" />
              <XRef ID="MONDO:0013938" DB="MONDO" />
              <XRef Type="MIM" ID="614872" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10245" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17436" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 7A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013938" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD7A</ElementValue>
                <XRef ID="GTR000522755" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 8 (CG8, equivalent to CGA) have mutations in the PEX26 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15866" />
                <XRef ID="15866" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3888385" DB="MedGen" />
              <XRef ID="MONDO:0013938" DB="MONDO" />
              <XRef Type="MIM" ID="614872" DB="OMIM" />
            </Trait>
            <Trait ID="17437" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7B</ElementValue>
                <XRef ID="MONDO:0013939" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD7B</ElementValue>
                <XRef Type="MIM" ID="614873" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX26 gene have cells of complementation group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614873" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15867" />
                <XRef ID="15867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C3553951" DB="MedGen" />
              <XRef ID="MONDO:0013939" DB="MONDO" />
              <XRef Type="MIM" ID="614873" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7859472" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_017929.6:c.27_58dup|OMIM:614872" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201505" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.6:c.27_58dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614872" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8550014" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="21159329|MedGen:C3539168;C3553951" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004595726" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12851857</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg20Glnfs*73) in the PEX26 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX26 are known to be pathogenic (PMID: 12851857, 21031596). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX26-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.18561164_18561165insCTGCAGCCCCCCTCAGGGGGCTCGGGGGACCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3539168" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553951" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8550014" TraitType="Disease" MappingType="XRef" MappingValue="C3553951" MappingRef="MedGen">
        <MedGen CUI="C3553951" Name="Peroxisome biogenesis disorder 7B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8550014" TraitType="Disease" MappingType="XRef" MappingValue="C3539168" MappingRef="MedGen">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7859472" TraitType="Disease" MappingType="XRef" MappingValue="614872" MappingRef="OMIM">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

